Literature DB >> 10172408

Congenital and acquired anophthalmia.

L F Handler1, K L Heher, J A Katowitz.   

Abstract

Anophthalmia is an absence of ocular tissue in the orbit. Important aspects in the diagnosis, evaluation, and treatment of both congenital and acquired anophthalmic patients are reviewed. Congenital and acquired anophthalmia differ in etiology, but many concepts of management can apply to either category. Specific steps in the evaluation and treatment including the proper timing for medical and surgical intervention will be discussed. The major goals for the ophthalmologist are to optimize motility and symmetry of the eyelids and orbit and coordinate efforts with other medical specialties.

Entities:  

Mesh:

Year:  1994        PMID: 10172408

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  5 in total

1.  Injectable self inflating hydrogel pellet expanders for the treatment of orbital volume deficiency in congenital microphthalmos: preliminary results with a new therapeutic approach.

Authors:  M P Schittkowski; R F Guthoff
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

2.  The management of orbital cysts associated with congenital microphthalmos and anophthalmos.

Authors:  C J McLean; N K Ragge; R B Jones; J R O Collin
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

3.  [Congenital clinical anophthalmia and blind microphthalmia].

Authors:  M P Schittkowski; K K H Gundlach; R F Guthoff
Journal:  Ophthalmologe       Date:  2003-06-21       Impact factor: 1.059

4.  [Treatment of congenital clinical anophthalmos with high hydrophilic hydrogel expanders].

Authors:  M P Schittkowski; K K H Gundlach; R F Guthoff
Journal:  Ophthalmologe       Date:  2003-06-25       Impact factor: 1.059

5.  Assessing the results of anophthalmic prostheses.

Authors:  Yoav Vardizer; Tamer Sobeh; Daphna Landau Prat; Guy J Ben Simon; Oren Tomkins-Netzer
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.